Cryogenx

London, United Kingdom Founded: 2019 • Age: 7 yrs
Portable body cooling devices are manufactured for heatstroke treatment.
Annual revenue - Latest available
Total funding $3.2M 2 rounds
Employees 8 Tracked headcount
Investors 2 Known backers
Products 1 Services tracked
Competitors - Brand Intelligence

About Cryogenx

Cryogenx is a company based in London (United Kingdom) founded in 2019 by Matt Anderson. Cryogenx has raised $3.23 million across 2 funding rounds from investors including British Design Fund and UKI2S. The company has 8 employees as of December 31, 2024. Cryogenx offers products and services including CGX1 Device.

  • Headquarter London, United Kingdom
  • Employees 8 as on 31 Dec, 2024
  • Founders Matt Anderson
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Cryogenx Ltd
  • Date of Incorporation 16 Dec, 2019
  • Jurisdiction LONDON, ENGLAND
Operational Areas
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $3.23 M (USD)

    in 2 rounds

  • Latest Funding Round
    $2.22 M (USD), Seed

    Jul 15, 2025

  • Investors
  • Employee Count
    8

    as on Dec 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Cryogenx

Cryogenx offers a comprehensive portfolio of products and services, including CGX1 Device.

Product name locked
Category locked
Primary

Portable device for rapid body cooling during heatstroke emergencies.

Funding Insights of Cryogenx

Cryogenx has successfully raised a total of $3.23M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $2.22 million completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Cryogenx

Cryogenx has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include British Design Fund and UKI2S.

All
Venture Fund
Investor Description Founded Year Domain Location
Investment and mentoring are provided to British product startups.
Locked Locked Locked
Early-stage innovations are funded by UKI2S across key sectors.
Locked Locked Locked
Premium access

Investor details for Cryogenx

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Cryogenx

Investments
Premium access

Investment portfolio details for Cryogenx

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Cryogenx

Premium access

Detailed financials for Cryogenx

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Cryogenx Comparisons

Cryogenx Primary company
Description
Portable body cooling devices are manufactured for heatstrok...
Location
London, United Kingdom
Founded Year
2019
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
8
As of 2024
Premium access

Peer comparison for Cryogenx

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Cryogenx

Premium access

Detailed competitors of Cryogenx

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Cryogenx

Premium access

Complete news archive for Cryogenx

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Cryogenx

Cryogenx was founded in 2019 and raised its 1st funding round 5 years after it was founded.

Cryogenx is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.

Matt Anderson is the current CEO of Cryogenx. They have also founded this company.

Cryogenx is a funded company, having raised a total of $3.23M across 2 funding rounds to date.

As of Dec 31, 2024, the latest employee count at Cryogenx is 8.

Cryogenx was founded in 2019 in London, United Kingdom, and operates in the medical device sector. Portable body cooling technology is produced by the company to address heatstroke situations. The Cryogenx CGX1, an on-demand portable device, is offered for body cooling applications. Focus is placed on heat stroke treatment solutions, with manufacturing and distribution centered in the UK.

Cryogenx offers CGX1 Device.

Cryogenx has 2 investors. Key investors include British Design Fund, and UKI2S.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available